SIGA to Hold Conference Call on Monday, December 14, 2009 at 8:30 A.M. ET
* Press Release
* Source: SIGA Technologies, Inc.
* On 6:03 pm EST, Friday December 11, 2009
*
Companies:
o Siga Technologies Inc.
NEW YORK, Dec. 11, 2009 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA - News), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that it will hold a conference call to discuss the Biomedical Advanced Research & Development Authority's (BARDA) amendment today to the outstanding Request for Proposal for Smallpox Antiviral for The Strategic National Stockpile (RFP-BARDA-09-35).
Related Quotes
Symbol Price Change
SIGA 5.24 -2.08
Chart for SIGA Technologies Inc.
{"s" : "siga","k" : "c10,l10,p20,t10","o" : "","j" : ""}
Participants should call 888-684-1264 (United States/Canada) or 913-312-1450 (International) and request the SIGA Technologies call or utilize the confirmation code 3214157. A live broadcast of the conference call will also be available via the Internet at siga.com.
If you are unable to participate, an audio replay of the call will be available beginning two hours after the call and will be available until 11:59 p.m. on December 21, 2009 by dialing 888-203-1112 (domestic) or 719-457-0820 (international) using replay pass code 3214157. The webcast of the event will also be archived on the Company's website for 30 days.
About SIGA Technologies, Inc.
SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents to fight potential bio-warfare pathogens. SIGA has antiviral programs targeting smallpox and other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). For more information about SIGA, please visit SIGA's web site at siga.com.
The SIGA Technologies, Inc. logo is available at globenewswire.com |
